Claims
- 1. A method for the treatment of arteriosclerosis in mammals, which comprises administering a dihydropyridine compound of the formula: ##STR3## in which R.sup.2, R.sup.3 and R.sup.4 are each C.sub.1 -C.sub.4 alkyl, or a pharmaceutically acceptable salt thereof, to said mammal in need of treatment in an effective antiarteriosclerotic dosage of 0.01-20 mg/kg single dose to a level of 0.5-1000 mg daily dose.
- 2. A method for the treatment of arteriosclerosis in mammals, which comprises administering the isopropyl ester of 6-cyano-5-methoxycarbonyl-2-methyl-4-(3-nitrophenyl)-1, 4-dihydropyridine-3-carboxylic acid, or a pharmaceutically acceptable salt thereof, to said mammal in need of treatment in an effective anti-arteriosclerotic dosage of 0.01-20 mg/kg single dose to a level of 0.5-1000 mg daily dose.
Priority Claims (1)
Number |
Date |
Country |
Kind |
8431119 |
Dec 1984 |
GBX |
|
Parent Case Info
This application is a continuation-in-part of Application Ser. No. 801,842, filed Nov. 26, 1985, now abandoned.
US Referenced Citations (4)
Foreign Referenced Citations (1)
Number |
Date |
Country |
3307422 |
Sep 1984 |
DEX |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
801842 |
Nov 1985 |
|